7 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34560172 | MK212, a 5-hydroxytryptamine 2C receptor agonist, reverses prepulse inhibition deficits in the medial prefrontal cortex and ventral hippocampus. | 2022 Mar 8 | 1 |
2 | 31968217 | Fluoxetine improves behavioural deficits induced by chronic alcohol treatment by alleviating RNA editing of 5-HT2C receptors. | 2020 Mar | 3 |
3 | 29548885 | Activation of 5-HT2C (but not 5-HT1A) receptors in the amygdala enhances fear-induced antinociception: Blockade with local 5-HT2C antagonist or systemic fluoxetine. | 2018 Jun | 1 |
4 | 27059332 | Rat exposure in mice with neuropathic pain induces fear and antinociception that is not reversed by 5-HT2C receptor activation in the dorsal periaqueductal gray. | 2016 Jul 1 | 1 |
5 | 26380122 | Genotype-Dependent Difference in 5-HT2C Receptor-Induced Hypolocomotion: Comparison with 5-HT2A Receptor Functional Activity. | 2015 | 2 |
6 | 17141810 | Activation of the brain 5-HT2C receptors causes hypolocomotion without anxiogenic-like cardiovascular adjustments in mice. | 2007 Mar | 2 |
7 | 17415471 | Effect of 5HT2C-receptor agonist MK-212 on blood corticosterone level and behavior in mice. | 2006 Nov | 1 |